Establishment of drug utilization evaluation criteria and rationality analysis of clinical application of Betahistine Hydrochloride for Injection
Objective To establish the evaluation criteria for clinical rational drug use of Betahistine Hydrochloride for Injection,and to provide reference for clinical rational application. Methods Based on the drug instructions of Betahistine Hydrochloride for Injection,referring to relevant guidelines and expert consensus,AHP-TOPSIS method was used to evaluate the rationality of the use of Betahistine Hydrochloride for Injection in the Lu'an Hospital Affiliated to Anhui Medical University from January to December 2023. Results A total of 165 medical records were included,of which 15 cases (9.09％) had a reasonable Ci ≥ 0.8 medical record rating,86 cases ( 52.12％ ) had a basically reasonable 0.6 ≤ Ci<0.8 medical record rating,and 64 cases (38.79％) had an unreasonable Ci<0.6 medical record rating. The irrational use of Betahistine Hydrochloride for Injection is mainly manifested in indications,solvents,administration methods,special populations and efficacy evaluation. Conclusion There are still many problems in the use of Betahistine Hydrochloride for Injection in the hospital,and management needs to be strengthened. The evaluation method based on AHP-TOPSIS is scientific and reasonable,which provides a new method for the evaluation of drug rationality.
Betahistine Hydrochloride for InjectionAHPTOPSISdrug use evaluationindicationssolvent
NETL
NSTL
万方数据
